PreveCeutical Medical Inc (18H) — Capital Reinvestment Ratio
Latest as of September 2020:
0.04x
PreveCeutical Medical Inc (18H) has a Capital Reinvestment Ratio of 0.04x as of September 2020, meaning it reinvests 0% of its operating cash flow (€520.22K) in capital expenditures (€21.18K). See PreveCeutical Medical Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
€520.22K
EUR
Capital Expenditures
€21.18K
EUR
Data as of
Sep 2020
Most recent filing
PreveCeutical Medical Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks PreveCeutical Medical Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for PreveCeutical Medical Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for PreveCeutical Medical Inc from 2020 to 2020. For live market cap and broader valuation context, see market value of PreveCeutical Medical Inc.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.04x | €64.59K | €2.65K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow